This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Maruho Co., Ltd.
Drug Names(s): CLS 003, CLS-003, Ionic Contra Viral Therapy, ICVT
Description: CLS-003 is an antiviral topical formulation of furosemide and digoxin designed to target NKCC2.
Additional information available to subscribers only: